Search

Search Constraints

You searched for: Author/Creator Gibson, Michael

Search Results

1. Corrigendum to "Cetuximab activity in dysplastic lesions of the upper aerodigestive tract" [Oral Oncol. 53 (2016) 60–66]. (June 2016)

4. 354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer. (9th November 2020)

5. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. (18th October 2021)

6. Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. Issue 7 (23rd March 2022)

7. Cetuximab activity in dysplastic lesions of the upper aerodigestive tract. (February 2016)

8. Phase II study of erlotinib and docetaxel with concurrent intensity‐modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. (26th February 2016)

9. SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention. Issue 2 (August 2020)

10. Cetuximab activity in dysplastic lesions of the upper aerodigestive tract. (February 2016)